{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:53:38Z","timestamp":1790132018839,"version":"4.0.1"},"reference-count":80,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1080\/03009740310004333","type":"journal-article","created":{"date-parts":[[2004,2,20]],"date-time":"2004-02-20T12:11:44Z","timestamp":1077279104000},"page":"325-336","source":"Crossref","is-referenced-by-count":39,"title":["Multidrug resistance proteins in rheumatoid arthritis, role in disease\u2010modifying antirheumatic drug efficacy and inflammatory processes: an overview"],"prefix":"10.1080","volume":"32","author":[{"given":"G","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RJ","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BAC","family":"Dijkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"CIT0001","first-page":"307 \u201410","volume":"85","author":"Feldmann M","year":"1996","journal-title":"Rheumatoid arthritis. Cell"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","volume":"2","author":"Smolen JS","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"5\u2014 26","DOI":"10.1007\/s002810100063","volume":"23","author":"Fathy N","year":"2001","journal-title":"Springer Semin Immunopathol"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/art.10228"},{"key":"CIT0005","first-page":"347\u2014 56","volume":"46","author":"Landewe RB","year":"2002","journal-title":"COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"619 \u2014 32","DOI":"10.1016\/S0950-3579(05)80305-X","volume":"9","author":"Wolfe F","year":"1995","journal-title":"Baillieres Clin Rheumatol"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.9.975"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"15\u2014 9","DOI":"10.1136\/ard.62.2.159","volume":"62","author":"Morgan C","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","volume":"58","author":"Endicott JA","year":"1989","journal-title":"Annu Rev Biochem"},{"key":"CIT0010","first-page":"48 \u201458","volume":"2","author":"Gottesman MM","year":"2002","journal-title":"Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/PL00000912","volume":"58","author":"Litman T","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1042\/bj2720281"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","volume":"71","author":"Borst P","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"CIT0014","first-page":"1156","volume":"11","author":"Dean M","year":"2001","journal-title":"The human ATP-binding cassette (ABC) transporter superfamily. Genome Res"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0959-8049(96)00069-X","volume":"32","author":"Lehnert M","year":"1996","journal-title":"Eur J Cancer"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0959-8049(96)00057-3","volume":"32","author":"Germann UA","year":"1996","journal-title":"Eur J Cancer"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","volume":"258","author":"Cole SP","year":"1992","journal-title":"Science"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1038\/12487"},{"key":"CIT0021","first-page":"7476","volume":"97","author":"Wijnholds J","year":"2000","journal-title":"Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA"},{"key":"CIT0022","first-page":"175","volume":"59","author":"Kool M","year":"1999","journal-title":"Cancer Res"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.2.351"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.202"},{"key":"CIT0027","first-page":"3458","volume":"61","author":"Maliepaard M","year":"2001","journal-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res"},{"key":"CIT0028","first-page":"3163","volume":"271","author":"Borgnia MJ","year":"1996","journal-title":"Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem"},{"key":"CIT0029","first-page":"4048","volume":"63","author":"Chen ZS","year":"2003","journal-title":"Cancer Res"},{"key":"CIT0030","first-page":"988","volume":"56","author":"Jedlitschky G","year":"1996","journal-title":"Cancer Res"},{"key":"CIT0031","first-page":"1237","volume":"148","author":"Flens MJ","year":"1996","journal-title":"Tissue distribution of the multidrug resistance protein. Am J Pathol"},{"key":"CIT0032","first-page":"23","volume":"94","author":"Legrand O","year":"1996","journal-title":"Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)01026-2"},{"key":"CIT0035","first-page":"1073","volume":"62","author":"Laupeze B","year":"2001","journal-title":"Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. Hum Immunol"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0092-8674(00)00179-3","volume":"103","author":"Robbiani DF","year":"2000","journal-title":"Cell"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.4049\/jimmunol.168.4.1572","volume":"168","author":"Schroeijers AB","year":"2002","journal-title":"J Immunol"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","volume":"7","author":"Zhou S","year":"2001","journal-title":"Nat Med"},{"key":"CIT0039","first-page":"729","volume":"60","author":"Cutolo M","year":"2001","journal-title":"Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis"},{"key":"CIT0040","first-page":"247","volume":"47","author":"Genestier L","year":"2000","journal-title":"Mechanisms of action of methotrexate. Immunopharma-cology"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/art.1780391203","volume":"39","author":"Cronstein BN","year":"1996","journal-title":"Methotrexate and its mechanism of action. Arthritis Rheum"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood.V93.5.1677","volume":"93","author":"Rots MG","year":"1999","journal-title":"Blood"},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","volume":"335","author":"Gorlick R","year":"1996","journal-title":"N Engl J Med"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.1.4"},{"key":"CIT0046","first-page":"2532","volume":"59","author":"Hooijberg JH","year":"1999","journal-title":"Cancer Res"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.12.6914"},{"key":"CIT0049","first-page":"5035","volume":"62","author":"Volk EL","year":"2002","journal-title":"Cancer Res"},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0006-2952(02)01615-5","volume":"65","author":"Hooijberg JH","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.64.2.220","volume":"64","author":"Stark M","year":"2003","journal-title":"Mol Pharmacol"},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002281-200105000-00005","volume":"13","author":"Goekoop YP","year":"2001","journal-title":"CUff Opin Rheumatol"},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0006-2952(98)00217-2","volume":"56","author":"Vezmar M","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.11.841"},{"key":"CIT0056","first-page":"2484","volume":"29","author":"Seidman EG","year":"2002","journal-title":"J Rheumatol"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/ard.45.5.389","volume":"45","author":"Glennas A","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"CIT0059","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199507203330301","volume":"333","author":"Tugwell P","year":"1995","journal-title":"N Engl J Med"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0959-8049(93)90393-T","volume":"29","author":"Wright KA","year":"1993","journal-title":"Eur J Cancer"},{"key":"CIT0061","first-page":"146","volume":"59","author":"Maillefert JF","year":"2000","journal-title":"Effects of cyclosporin at various concentrations on dex-amethasone intracellular uptake in multidrug resistant cells. Ann Rheum Dis"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2451"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1006\/smim.2001.0322"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1038\/nm1197-1275"},{"key":"CIT0067","first-page":"97","volume":"44","author":"Salmon SE","year":"1996","journal-title":"J Rheumatol Suppl"},{"key":"CIT0068","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V88.5.1747.1747","volume":"88","author":"Drach J","year":"1996","journal-title":"Blood"},{"key":"CIT0069","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4049\/jimmunol.163.5.2621","volume":"163","author":"Eisenbraun MD","year":"1999","journal-title":"J Immunol"},{"key":"CIT0071","first-page":"2552","volume":"61","author":"de Jong MC","year":"2001","journal-title":"Cancer Res"},{"key":"CIT0072","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","volume":"8","author":"Lee DH","year":"1998","journal-title":"Trends Cell Biol"},{"key":"CIT0073","first-page":"268","volume":"3","author":"Sukhai M","year":"2000","journal-title":"J Pharm Pharm Sci"},{"key":"CIT0074","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0898-6568(95)00018-K","volume":"7","author":"Rohlff C","year":"1995","journal-title":"Cell Signal"},{"key":"CIT0076","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1529-0131(199905)42:5<948::AID-ANR13>3.0.CO;2-L","volume":"42","author":"Tak PP","year":"1999","journal-title":"Arthritis Rheum"},{"key":"CIT0077","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1074\/jbc.M209186200","volume":"278","author":"Assaraf YG","year":"2003","journal-title":"J Biol Chem"},{"key":"CIT0079","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/jnci\/89.11.807","volume":"89","author":"Stein U","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"CIT0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1568-1637(02)00046-6","volume":"2","author":"Efferth T","year":"2003","journal-title":"Ageing Res Rev"},{"key":"CIT0084","first-page":"430","volume":"35","author":"Maillefert JF","year":"1996","journal-title":"The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br J Rheumatol"},{"key":"CIT0085","first-page":"2014","volume":"42","author":"Yudoh K","year":"1999","journal-title":"Increased expression of multidrug resistance of P-glycoprotein on Thl cells correlates with drug resistance in rheumatoid arthritis. Arthritis Rheum"},{"key":"CIT0087","first-page":"5134","volume":"46","author":"Maillefert JF","year":"2002","journal-title":"Expression of the multidrug resistance p-glycoprotein on peripheral blood monocytes as a predictor of response to second-line therapy in rheumatoid arthritis. Arthritis Rheum"},{"key":"CIT0088","first-page":"83","volume":"15","author":"Jorgensen C","year":"1995","journal-title":"Expression of a multidrug resistance gene in human rheumatoid synovium. Rheumatol Int"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4615-2007-8_3","volume":"78","author":"Fisher GA","year":"1995","journal-title":"The reversal of multidrug resistance. Cancer Treat Res"},{"key":"CIT0090","first-page":"1250","volume":"34","author":"Duffy CP","year":"1998","journal-title":"Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). Eur J Cancer"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.1.4.22"},{"key":"CIT0092","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00001622-200009000-00011","volume":"12","author":"Tan B","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"CIT0093","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1006487003814","volume":"18","author":"van Zuylen L","year":"2000","journal-title":"Invest New Drugs"},{"key":"CIT0094","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","volume":"10","author":"Thomas H","year":"2003","journal-title":"Cancer Control"},{"key":"CIT0095","first-page":"230","volume":"49","author":"Langmann T","year":"2003","journal-title":"Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem"},{"key":"CIT0096","first-page":"134","volume":"88","author":"van der Pol MA","year":"2003","journal-title":"Haematologica"},{"key":"CIT0098","first-page":"19","volume":"13","author":"Zamber CP","year":"2003","journal-title":"Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics"},{"key":"CIT0099","doi-asserted-by":"crossref","first-page":"38108","DOI":"10.1074\/jbc.M105160200","volume":"276","author":"Ito K","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03009740310004333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:21:59Z","timestamp":1682641319000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03009740310004333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,7,12]]},"published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1080\/03009740310004333"],"URL":"https:\/\/doi.org\/10.1080\/03009740310004333","relation":{},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}